4.2 Article

Clinical Significance of CD66b Expression in Non-Small Cell Lung Cancer

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

CHID1 Is a Novel Prognostic Marker of Non-Small Cell Lung Cancer

Olga V. Kovaleva et al.

Summary: In this study, immune cell markers in NSCLC specimens were evaluated, with CD163 and CD206 showing prognostic value, especially in patients with squamous cell lung carcinoma and adenocarcinoma. Additionally, iNOS and CHID1 were found to be expressed in tumor cells and associated with prognosis, indicating potential as therapeutic targets in NSCLC.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Multidisciplinary Sciences

Neutrophils dominate the immune cell composition in non-small cell lung cancer

Julia Kargl et al.

NATURE COMMUNICATIONS (2017)

Review Oncology

On the dual roles and polarized phenotypes of neutrophils in tumor development and progression

H. Piccard et al.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2012)

Review Cell Biology

Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation

G. Solinas et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2009)